MTVA - MetaVia Inc.
1.51
0.110 7.285%
Share volume: 84,359
Last Updated: 04-20-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.40
0.11
0.08%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 11-07-2024 | 03-20-2025 | 05-14-2025 | 08-07-2025 | 11-06-2025 | 03-26-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 6.259 M | 5.585 M | 3.886 M | 4.301 M | 3.475 M | 2.046 M | |
| Selling general and admin | 1.742 M | 1.527 M | 1.559 M | 1.981 M | 1.561 M | 1.805 M | |
| Research and development | 4.517 M | 4.058 M | 2.327 M | 2.320 M | 1.914 M | 241.000 K | |
| Total expenses | 6.259 M | 5.585 M | 3.886 M | 4.301 M | 3.475 M | 2.046 M | |
| -10.77% | -30.42% | 10.68% | -19.20% | -41.12% | |||
| Operating income | -6.259 M | -5.585 M | -3.886 M | -4.301 M | -3.475 M | -2.046 M | |
| Ebit | -5.962 M | -5.413 M | -3.799 M | -4.141 M | -3.528 M | -2.015 M | |
| Pretax income | -5.652 M | -5.173 M | -3.671 M | -3.995 M | -3.377 M | -1.930 M | |
| -8.47% | -29.04% | 8.83% | -15.47% | -42.85% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.652 M | -5.173 M | -3.671 M | -3.995 M | -3.377 M | -1.930 M | |
| 8.47% | 29.04% | -8.83% | 15.47% | 42.85% |